Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Oncolytics REOLYSIN On The RAS Warpath - Seeking Alpha Post

http://seekingalpha.com/instablog/383010-chinook-traveler/28237-oncolytics-reolysin-on-the-ras-warpath

Notable quotes.

"As Oncolytics Biotech have stated, a significant clinical opportunity for REOLYISN is in the treatment of patients with metastatic cancers including colorectal and non-small cell lung cancer who have a mutated KRAS gene...

A U.K. translational clinical trial investigating REOLYSIN in patients with metastatic colorectal cancer has also been initiated. A clinical benefit response rate of 93% was obtained in treated lesions of a U.K. Phase II combination radiation and REOLYSIN trial.

Oncolytics announced that it has successfully completed an initial 100-liter production run of REOLYSIN under cGMP conditions and completed the lyophilization (freeze-drying) formulation development program a stable form for pharmaceutical distribution should their product be approved by the FDA. Oncolytics has more than 200 patents issued worldwide which cover mainly reovirus and other oncolytic viruses (adenovirus, herpes simplex virus).

...All clinical trials to date have clearly demonstrated a significant improvement of seriously ill cancer patients."
endquote


The value of running all these parallel Phase II studies will be evident someday as the breath of this product's potential market gets larger as we go along. Does anybody else get the feeling ONCY is fueled and ready to launch?

onco_investor